Tuberculosis Latente; Tuberculosis Pulmonar; Tuberculosis; Humanos; Prisiones; Metaanálisis en Red; Tuberculosis/diagnóstico; Tuberculosis Pulmonar/diagnóstico; Tuberculosis Pulmonar/epidemiología; Tuberculosis Latente/diagnóstico; Tuberculosis Latente/epidemiología; Metaanálisis como Asunto; Revisiones Sistemáticas como Asunto

95% CI ­ 95% confidence intervals; AFB ­ Acid-fast bacilli; AUC ­ Area under the curve; BAL ­ Bronchoalveolar lavage; BCG ­ Bacille Calmette Guerin; CD4 ­ Cluster of differentiation 4; CT ­ Computed tomography; CXR ­ Chest radiography; DNA ­ Deoxyribonucleic acid; DOTS ­ Directly observed therapy strategy; ECDC ­ European Centre for Disease Prevention and Control; EPTB ­ Extrapulmonary tuberculosis; FL LPA ­ First-line line probe assay; FM ­ Fluorescence microscopy; FN ­ False-negative; FP ­ False-positive; FPR ­ False-positive rate; HBC ­ High burden country; HIV ­ Human immunodeficiency virus; HSROC ­ Hierarchical summary receiver operating characteristic; IGRA ­ Interferon-gamma release assay; LAM ­ Lipoarabinomannan; LJ ­ Löwenstein-Jensen; LPA ­ Line probe assay; LTBI ­ Latent tuberculosis infection; MDR TB ­ Multidrug-resistant tuberculosis; MGIT ­ Mycobacterial growth inhibitor tubes; MMR ­ Mass miniature radiography; MRI ­ Magnetic resonance imaging; NAAT ­ Nucleic acid amplification test; NMA ­ Network meta-analysis; PCR ­ Polymerase chain reaction; PICOS ­ Population, Intervention, Comparison, Outcomes, Setting; PRISMA ­ Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PROSPERO ­ International Prospective Register of Systematic Reviews; PTB ­ Pulmonary TB; QUADAS-2 ­ Quality Assessment of Diagnostic Accuracy Studies (revised tool); ROC ­ Receiver Operating Characteristic; SD ­ Standard deviation; SDGs ­ Sustainable Development Goals; SL LPA ­ Second-line line probe assay; SROC ­ Sum ROC; STD ­ Sexually transmitted diseases; Sn ­ Sensitivity; Sp ­ Specificity; TB ­ Tuberculosis; TB-LAMP ­ Loop-mediated isothermal amplification; TN ­ True-negative; TNF ­ Tumor necrosis factor; TP ­ True-positive; TPR ­ True-positive rate; TST ­ Tuberculin skin test (Mendel-Mantoux-Test); UV ­ Ultraviolet; WHO ­ World Health Organization; ZN ­ Ziehl-Neelsen; active case finding; entry screening; prison; tuberculosis